FOXC2-AS1

gene
On this page

Also known as ODRUL

Summary

FOXC2-AS1 (FOXC2 antisense RNA 1, HGNC:50665) is a long non-coding RNA gene on chromosome 16q24.1.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:50665
Approved symbolFOXC2-AS1
NameFOXC2 antisense RNA 1
Location16q24.1
Locus typeRNA, long non-coding
StatusApproved
AliasesODRUL
Ensembl geneENSG00000260944
Ensembl biotypelncRNA
Entrez103752587
RNAcentralURS000050E6E3 — lncRNA, 319 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 11 lncRNA

ENST00000563280, ENST00000809048, ENST00000809049, ENST00000809050, ENST00000809051, ENST00000809052, ENST00000809053, ENST00000809054, ENST00000809055, ENST00000809056, ENST00000809057

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000563280 — 2 exons

ExonStartEnd
ENSE000042044558656495686565318
ENSE000042044638656761786567929

Expression profiles

Bgee: expression breadth ubiquitous, 105 present calls, max score 93.05.

FANTOM5 (CAGE): breadth broad, TPM avg 0.5532 / max 16.8180, expressed in 341 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1584470.5233333
2079960.02999

Top tissues by expression

105 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.05gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.92gold quality
hindlimb stylopod muscleUBERON:000425270.48gold quality
stromal cell of endometriumCL:000225568.72gold quality
calcaneal tendonUBERON:000370168.16gold quality
ascending aortaUBERON:000149667.37gold quality
thoracic aortaUBERON:000151567.18gold quality
tibial arteryUBERON:000761067.15gold quality
popliteal arteryUBERON:000225067.03gold quality
descending thoracic aortaUBERON:000234566.27gold quality
gall bladderUBERON:000211066.13gold quality
left coronary arteryUBERON:000162665.63gold quality
olfactory segment of nasal mucosaUBERON:000538664.40gold quality
prefrontal cortexUBERON:000045159.27gold quality
smooth muscle tissueUBERON:000113559.15gold quality
right coronary arteryUBERON:000162558.96gold quality
bloodUBERON:000017857.68gold quality
muscle of legUBERON:000138357.55gold quality
endometriumUBERON:000129557.25gold quality
liverUBERON:000210757.12gold quality
monocyteCL:000057656.62gold quality
islet of LangerhansUBERON:000000656.56gold quality
heartUBERON:000094856.40gold quality
lymph nodeUBERON:000002956.36gold quality
kidneyUBERON:000211356.25gold quality
heart left ventricleUBERON:000208455.98gold quality
tibial nerveUBERON:000132355.75gold quality
fundus of stomachUBERON:000116055.37gold quality
right lobe of liverUBERON:000111455.27gold quality
gastrocnemiusUBERON:000138855.13gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.66

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 9)

  • Nrf2-mediated lncRNA ODRUL was indispensable for silver nanoparticle-induced toxicity in erythroid cells. (PMID:28351005)
  • a high level of FOXC2-AS1 was associated with poor prognosis of BC patients. (PMID:29562954)
  • lncRNA FOXC2-AS1 accelerated the tumor progression of prostate cancer cells by regulating the proliferation and tumor growth through miR-1253/EZH2 axis. (PMID:30389560)
  • Expression level of FOXC2-AS1 in lung cancer (LCa) specimens was considerably higher than in normal tissues and correlated with higher incidence of distant metastasis and lower overall survival rate. miR-107 expression was found significantly reduced in LCa cell lines and tissues and showed a negative correlation with FOXC2-AS1. Luciferase reporter gene assay verified direct binding of FOXC2-AS1 to downstream miRNA-107. (PMID:30720176)
  • LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway. (PMID:32513911)
  • LncRNA FOXC2-AS1 stimulates proliferation of melanoma via silencing p15 by recruiting EZH2. (PMID:32964984)
  • H3K27ac-induced FOXC2-AS1 accelerates tongue squamous cell carcinoma by upregulating E2F3. (PMID:34358374)
  • LncRNA ODRUL regulates progression of osteosarcoma by regulating IL-6 via sponging miR-6874-3p. (PMID:35114192)
  • FOXC2-AS1/FOXC2 axis mediates matrix stiffness-induced trans-differentiation of hepatic stellate cells into fibrosis-promoting myofibroblasts. (PMID:37705741)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): lymphedema-distichiasis syndrome